Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Lymphatics in lung disease.

El-Chemaly S, Levine SJ, Moss J.

Ann N Y Acad Sci. 2008;1131:195-202. doi: 10.1196/annals.1413.017. Review.

2.

Molecular mechanisms of lymphangiogenesis.

Takahashi M, Yoshimoto T, Kubo H.

Int J Hematol. 2004 Jul;80(1):29-34. Review.

PMID:
15293565
3.

[Lymphangiogenesis].

Hosono K, Majima M.

Nihon Yakurigaku Zasshi. 2013 May;141(5):290-1. Review. Japanese. No abstract available.

PMID:
23665561
4.

Molecular control of lymphatic metastasis.

Achen MG, Stacker SA.

Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Review.

PMID:
18519975
5.

[Molecular mechanisms of lymphatic development].

Kubo H.

Seikagaku. 2004 Sep;76(9):1210-6. Review. Japanese. No abstract available.

PMID:
15524110
6.

[Advances in lymphangiogenesis and metastasis of tumor].

Yan XC, Yu DM, Liu FX.

Zhonghua Bing Li Xue Za Zhi. 2005 Jun;34(6):370-2. Review. Chinese. No abstract available.

PMID:
16185511
7.

Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Kubo H, Stacker SA, Achen MG.

Mol Cell Biol. 2005 Mar;25(6):2441-9.

8.

Lymphangiogenesis and cancer metastasis.

Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K.

Nat Rev Cancer. 2002 Aug;2(8):573-83. Review.

PMID:
12154350
9.

[Lymphangiogenesis and tumor progression].

Vittet D, Feige JJ.

Bull Cancer. 2007 Oct;94(10):881-6. Review. French.

10.

Lymphangiogenesis and lymphatic function in periodontal disease.

Berggreen E, Wiig H.

J Dent Res. 2013 Dec;92(12):1074-80. doi: 10.1177/0022034513504589. Epub 2013 Sep 12. Review.

PMID:
24029591
11.
12.

Targeting lymphangiogenesis to prevent tumour metastasis.

Achen MG, Mann GB, Stacker SA.

Br J Cancer. 2006 May 22;94(10):1355-60. Review.

13.

Tumor-induced lymphangiogenesis: a target for cancer therapy?

Thiele W, Sleeman JP.

J Biotechnol. 2006 Jun 25;124(1):224-41. Epub 2006 Feb 23. Review.

PMID:
16497404
14.

Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.

Lee AS, Lee JE, Jung YJ, Kim DH, Kang KP, Lee S, Park SK, Lee SY, Kang MJ, Moon WS, Kim HJ, Jeong YB, Sung MJ, Kim W.

Kidney Int. 2013 Jan;83(1):50-62. doi: 10.1038/ki.2012.312. Epub 2012 Aug 29.

15.

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG, Rupasinghe TW, Tull DL, Baldwin ME, Sloan EK, Fox SB, Achen MG, Stacker SA.

Cancer Cell. 2012 Feb 14;21(2):181-95. doi: 10.1016/j.ccr.2011.12.026.

16.

Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.

Saharinen P, Tammela T, Karkkainen MJ, Alitalo K.

Trends Immunol. 2004 Jul;25(7):387-95. Review. No abstract available.

PMID:
15207507
17.

Why and how do tumors stimulate lymphangiogenesis?

Cao Y.

Lymphat Res Biol. 2008;6(3-4):145-8. doi: 10.1089/lrb.2008.1007. Review.

PMID:
19093786
18.
19.

Molecular targeting of lymphatics for therapy.

Stacker SA, Hughes RA, Achen MG.

Curr Pharm Des. 2004;10(1):65-74. Review.

PMID:
14754406
20.

VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.

Koch M, Dettori D, Van Nuffelen A, Souffreau J, Marconcini L, Wallays G, Moons L, Bruyère F, Oliviero S, Noel A, Foidart JM, Carmeliet P, Dewerchin M.

J Pathol. 2009 Nov;219(3):356-64. doi: 10.1002/path.2605.

Supplemental Content

Support Center